AWM
TEVA icon

Abound Wealth Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Abound Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10
Closed -$81 – 781
2022
Q3 		$81 Buy
+10
New +$88 ﹤0.01% 724

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Abound Wealth Management's TEVA Position: Q4 2022 in Review

Abound Wealth Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2022, closing a stake of 10 shares — an estimated $81 sold.

Abound Wealth Management first reported a position in TEVA in Q3 2022 and held it in 1 quarter. The position peaked at $81 in Q3 2022. 421 funds tracked by Wall St. Rank hold TEVA as of Q4 2022.

  • Abound Wealth Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2022 after selling out during the quarter.
  • Abound Wealth Management sold 10 Teva Pharmaceutical Industries Limited shares in Q4 2022, an estimated $81.
  • Abound Wealth Management first reported a position in Teva Pharmaceutical Industries Limited in Q3 2022 and held it in 1 quarter.
  • Abound Wealth Management's Teva Pharmaceutical Industries Limited position peaked at $81 in Q3 2022.
  • 421 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2022.

Based on Abound Wealth Management's 13F filing for Q4 2022, filed 7 Aug 2024.